Page last updated: 2024-11-08

aromadendrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aromadendrene: do not confuse with aromadendrin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID177445
CHEBI ID166671
MeSH IDM0497858

Synonyms (14)

Synonym
(1as,4as,7s,7as,7br)-1,1,7-trimethyl-4-methylidene-2,3,4a,5,6,7,7a,7b-octahydro-1ah-cyclopropa[e]azulene
14682-34-9
CHEBI:166671
aromadendrene
(-)-10(14)-aromadendrene
beta-diploalbicene
l-aromadendrene
1h-cycloprop(e)azulene, decahydro-1,1,7-trimethyl-4-methylene-, (1as,4as,7s,7as,7br)-
aromadendrene, (-)-
(1as,4as,7s,7as,7br)-1,1,7-trimethyl-4-methylene-2,3,4a,5,6,7,7a,7b-octahydro-1ah-cyclopropa[e]azulene
DTXSID60881276
(1as,4as,7s,7as,7br)-1,1,7-trimethyl-4-methylenedecahydro-1h-cyclopropa[e]azulene
AKOS040752420
[1as,4aalpha,7abeta,7balpha,(-)]-decahydro-1,1,7alpha-trimethyl-4-methylene-1h-cyclopropa[e]azulene
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
sesquiterpenoidAny terpenoid derived from a sesquiterpene. The term includes compounds in which the C15 skeleton of the parent sesquiterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (13.33)29.6817
2010's10 (66.67)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.76 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index55.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]